The exposure of isolated adipocytes to insulin results in an -20-fold increase in the rate of glucose transport into the cell. This increase is mediated by the movement of a pool of intracellular vesicles containing the so-called insulin-responsive glucose transporter (GLUT4) to the cell surface. In the resting state, most of the GLUT4 molecules are sequestered inside the adipocyte in an as yet unidentified intracellular compartment. TGN38 is an integral membrane protein which has been shown to be predominantly localized to the trans Golgi network [Luzio, Brake, Banting, Howell, Braghetta and Stanley (1990) Biochem. J. 270, 97-102]. Here we investigate whether GLUT4 and TGN38 are co-localized in the murine 3T3-L1 adipocyte cell line. Immunoadsorption of intracellular vesicles containing GLUT4 with an anti-peptide antibody specific for this isoform did not deplete the low-density microsomal fraction of TGN38 in these cells; more-
INTRODUCTION
Insulin stimulates glucose disposal into peripheral tissues (muscle and fat). Acute insulin treatment of isolated adipocytes results in a 20-30-fold increase in the rate of glucose transport into these cells. The mechanism underlying this effect has been extensively studied, and it is now well established that most, if not all, of the increase in glucose transport elicited by insulin can be accounted for by an increase in the number of glucose transporters at the plasma membrane following the rapid movement (translocation) of a pool of intracellular vesicles containing transport proteins to the cell surface (Cushman and Wardzala, 1980; Suzuki and Kono, 1980; James et al., 1989; Zorzano et al., 1989; Calderhead et al., 1990; Slot et al., 1991a,b) . Adipocytes and muscle express a unique glucose transporter isoform termed GLUT4, or the insulin-responsive glucose transporter (for review see Bell et al., 1990; Gould and Bell, 1990) . In the resting state only about 5 % of the total cellular GLUT4 is at the surface of isolated rat adipocytes; upon exposure to insulin, 40-50 % of the GLUT4 is found at the cell surface, and there is a corresponding decrease in the amount of intracellular GLUT4 Calderhead et al., 1990; Slot et al., 1991a,b) . Upon removal of insulin, there is a rapid reversal of this translocation and GLUT4 re-appears inside the cell. This recycling of GLUT4 is similar to that observed with other continually recycling proteins. Levels of the bifunctional mannose 6-phosphate/ insulin-like growth factor-II receptor (M6PR/IGFIIR) also increase at the cell surface after insulin stimulation, and this over, no TGN38 was detected in the GLUT4-containing vesicles by immunoblotting with a TGN38-specific antiserum. Immunoadsorption of TGN38-containing vesicles and subsequent analysis of the proteins in these vesicles revealed that a detectable amount of GLUT4 (5-10 %) did co-localise with TGN38. The amount of GLUT4 in the TGN38-containing vesicles did not change in response to insulin. Immunofluorescence analysis of TGN38 and GLUT4 in these cells revealed markedly different staining patterns. Reversal of insulin-stimulated glucose transport and subsequent analysis of the TGN38-containing vesicles demonstrated that during the re-cycling of GLUT4 to the intracellular storage site there was no increase in the amount of GLUT4 co-localized with TGN38. Taken together, these results suggest that the trans Golgi network is not the major site of the intracellular GLUT4 pool within 3T3-L1 adipocytes.
protein recycles between the plasma membrane, prelysosomal intracellular compartments and the trans Golgi network (TGN) (Oka et al., 1984) . The transferrin receptor also recycles between the plasma membrane and endosomal compartments (Tanner and Lienhard, 1987; Davis et al., 1986) . In adipocytes and muscle, the translocation of GLUT4 has been demonstrated by several techniques, including specific labelling with a cell-impermeant photoactivatable glucose analogue Calderhead et al., 1990) , and by immuno-electron-microscopy with GLUT4-specific antibodies (Slot et al., 1991a,b) . However, despite these advances, the definitive identification of a specific intracellular compartment to which GLUT4 is sequestered in the absence of insulin remains to be achieved. Recent evidence has shown that GLUT4 undergoes a continual re-cycling process between the intracellular compartment and the plasma membrane, and that this pathway involves clathrin-coated pits and endosomes (Slot et al., 1991a,b; Piper et al., 1992; Jhun et al., 1992; Yang et al., 1992; Yang and Holman, 1993) . Immunoelectron-microscopy has identified GLUT4 in tubulo-vesicular structures located trans to the Golgi stack, suggesting that the compartment to which GLUT4 is localized may be the TGN; however, GLUT4 has also been localized to vesicular structures located in regions near the plasma membrane and in clusters throughout the cytoplasm (Blok et al., 1988; Slot et al., 1991a,b; Smith et al., 1991 Smith et al., ). 1992 ) and that, since certain integral membrane proteins can recycle between the TGN and the plasma membrane (Breitfeld et al., 1985; Duncan and Kornfeld, 1986; Stoorvogel et al., 1989; Ladinsky and Howell, 1992; Reaves et al., 1993; Meresse and Hoflack, 1993) , it might well be considered part of an endosomal membrane system (Luzio and Banting, 1993) . Thus the TGN would appear to be a prime candidate for the location of the intracellular pool of GLUT4 in non-insulin-stimulated adipocytes:> A procedure for the isolation of the intracellular glucosetransporter-containing vesicles, based on the specific adsorption of these vesicles to Staphylococcus aureus (Staph. a) cells coated with anti-transporter antibodies, has been described (Biber and Lienhard, 1986; Brown et al., 1988; Cain et al., 1992) . Analysis of these vesicles has demonstrated the presence of proteins related to the synaptic-vesicle VAMP (vesicle-associated microtubule proteins) protein family (Cain et al., 1992) , low-molecularmass GTP-binding proteins (Cormont et al., 1991) and has also shown that these vesicles are not enriched in the Golgi marker galactosyltransferase (Brown et al., 1988) , suggesting that, although the intracellular pool of GLUT4 might be in an endosomally related compartment, it is probably not in the Golgi stack itself.
One of the proteins which recycles between the TGN and the plasma membrane is a monotopic integral membrane protein designated TGN38 (Luzio et al., 1990; Ladinsky and Howell, 1992; Reaves et al., 1993) . Although this molecule recycles between the TGN and the plasma membrane, at steady state the vast majority is in the TGN. It is thus a convenient marker for this organelle. The availability of epitope-mapped monoclonal and polyclonal antibodies against TGN38 prompted us to determine whether GLUT4-containing vesicles are enriched for this protein, and to evaluate the role of the TGN in the recycling of this metabolically important glucose transporter. We demonstrate that the majority of the insulin-responsive glucose transporter, GLUT4, and the TGN marker protein, TGN38, do not co-localize within the intracellular vesicles of 3T3-L1 adipocytes. It is further shown that, after insulin stimulation of GLUT4 translocation, GLUT4 levels do not change in this compartment, suggesting that GLUT4 does not translocate through the TGN. Upon reversal of insulin-stimulated GLUT4 translocation, we see no evidence of GLUT4 re-sequestration involving the TGN.
MATERIAMS AND METHODS Materials':v
Formaldehyde-fixed Staphylococcus aureus cells were obtained from Calbiochem (Pansorbin) or from Sigma (Poole, Dorset, U.K.). Insulin, dexamethasone and 3-isobutyl-1-methylxanthine were from Sigma. Dulbecco's modified Eagle's medium (DMEM), Myoclone plus fetal-calf serum and all antibiotics were from Gibco (Paisley, Scotland, U.K.). Newborn-calf serum was from Flow Laboratories (Irvine, Scotland, U.K.). All other reagents were as described by Gould et al. (1992) .
Cell culture 3T3-L1 fibroblasts (American Tissue Culture Collection) were grown in 10% newborn-calf serum in DMEM at 37°C in an atmosphere of air/CO2 (9:1). Cells were passaged at subconfluency and then grown in the same media until confluent. Differentiation into the adipocyte phenotype was exactly as incubated in serum-free DMEM for 2 h. Cells were used between days 9 and 12 post-differentiation, and at passages between 3 and 10.
Deoxyglucose transport and Insulin reversal Deoxyglucose transport was assayed by the uptake of [1,2-3H]-deoxyglucose . Monolayers were washed with 3 x 3 ml of Krebs-Ringer phosphate buffer (KRP: 136 mM NaCl, 4.7 mM KCI, 1.25 mM MgSO4, 1.25 mM CaCl2, 5 mM sodium phosphate, pH 7.4) at 37°C and then covered with 1 ml of KRP. Insulin (100 nM) or carrier was present for the times indicated in the Figure legends, 0.25 ,uCi/ml). After incubation for 2 min, uptake was terminated by aspirating the medium and washing the monolayers three times with ice-cold PBS (150 mM NaCl, 10 mM NaH2PO4, pH 7.4). The cells were solubilized with 1.0 ml of 1 % Triton X-100, and the radioactivity in a sample was measured by liquidscintillation spectrometry. Uptake values were corrected for the non-specific association of [3H]deoxyglucose with the cells by subtracting the uptake in the presence of 10 ,uM cytochalasin B, a potent inhibitor of transport (Bloch, 1973) . This correction typically amounted to about 30 % of the uptake by basal cells. In all experiments described herein, the increase in deoxyglucose transport measured in response to treatment with 100 nM insulin for 30 min was between 10 and 22-fold, depending on the plating of the cells.
Insulin-stimulated glucose transport was reversed by the lowpH washing procedure described by Gibbs et al. (1986) . Monolayers of adipocytes were stimulated with insulin for 30 min, then washed three times with Krebs-Ringer Mes buffer (KRM: 136 mM NaCl, 4.7 mM KCI, 1.25 mM MgSO4, 1.25 mM CaCl2, 5 mM Mes, pH 6.0) containing 1 mg/ml BSA at 37 'C. After these washes, cells were incubated in KRM for the times indicated, washed once with KRM, twice with KRP, then assayed for deoxyglucose transport as described above.
Preparation of plasma membrane and low-density microsomal (LDM) membrane fractlons Subcellular fractionation of 3T3-L1 adipocytes was performed exactly as described by Piper et al. (1991) after treatment for 30 min with either 1 #M insulin or carrier. For the immunoadsorption experiments, the LDM membranes were prepared as follows: 10 cm plates of 3T3-LI adipocytes were incubated in serum-free DMEM for 2 h, then washed with 3 x 5 ml of KRP and covered with 10 ml of the same buffer. Cells were stimulated with insulin (100 nM) for the times indicated in the Figure legends, or treated with vehicle as a control. Cells were subsequently washed with 3 x 8 ml of ice-cold Buffer A (20 mM Hepes/KOH, 150 mM KCI, 2 mM MgCl2, pH 7.2), then scraped off the plates into 10 ml of the same buffer, 'but containing 1 /zg/ml pepstatin A, 200 ,uM di-isopropyl fluorophosphate and 10 #uM L-trans-epoxysuccinyl-leucylamido-4-guanidinobutane.
Cells were homogenized by 20 hand-driven strokes of a Teflon Dounce homogenizer, and the homogenates were centrifuged at 16000 gaV for 20 min at 4 'C. The fat cake was carefully aspirated, and the supernatant containing the low-density microsomes was decanted into fresh tubes before immunoadsorptions.
Immunoadsorptlons
Formaldehyde-fixed Staph. a. cells were extracted and washed exactly as described by Brown et al. (1988) . The cells were then described by Frost and Lane (1985) . Before use, cells were washed twice in Buffer A containing 1 % BSA, and loaded as described below with either anti-GLUT4 antibodies or serum, anti-TGN38 serum or irrelevant serum as a control (Brown et al., 1988) .
Before immunoadsorption of a specific vesicle population, the low-density microsomal fractions were 'pre-cleared' by incubation for 30 min at 4°C with irrelevant-IgG-coated Staph. a. cells, as this has been shown to decrease non-specific binding (Brown et al., 1988) . The Staph. a. cells were removed by centrifugation, and immunoadsorption of either GLUT4-or TGN38-containing vesicles was performed by slow rotation of a portion of the low-density microsomes with antibody-coated Staph. a. cells for 2 h at 4°C (-20,ug of affinity-purified anti-GLUT4 antibodies, 10 #1 of anti-GLUT4 serum, or 10 l1 or 25 ,ul of anti-TGN38 serum was used routinely for these adsorptions; corresponding amounts of irrelevant IgG or serum were used as controls). After 2 h, the Staph. a. cells were recovered and washed as described (Brown et al., 1988) , and the vesicle proteins were solubilized by incubation with 1 % Triton X-100 in PBS. After incubation with occasional agitation for 20 min, the Staph. a. cells were pelleted and the supernatant was carefully removed. Samples for electrophoresis were prepared by addition of 4 x SDS/PAGE sample buffer (Gibbs et al., 1986) directly to this supernatant. Note that most of the GLUT4 molecules present in the vesicles remained bound to the pelleted Staph. a. cells, and were thus not detectable in the solubilized vesicle fraction.
The supernatants from the immunoadsorptions were centrifuged at 100000 gav for 1 h at 4°C to pellet all membranes. The pellets were directly resuspended in SDS/PAGE sample buffer.
Electrophoresis and Immunoblotting
Proteins were separated on 10 % Laemmli gels and transferred to nitrocellulose as previously described .
Immunoblotting was performed exactly as described by .
Antibodies
The antibodies against the C-terminal 14 amino acids of the human isoform ofGLUT4 have been previously described , as has the rabbit antiserum against the C-terminal 21 amino acids of TGN38 (Wilde et al., 1992) . The anti-M6PR antibody was kindly given by Dr. Suzanne Pfeffer (Department of Biochemistry, Stanford University Medical Center, Stanford, CA, U.S.A.). Rhodamine-conjugated antibodies were obtained from Sigma.
Immunofluorescence 3T3-L1 fibroblasts were cultured and differentiated on 22 mm glass coverslips as described above, and processed for immunofluorescence analysis as previously described (Reaves et al., 1993) .
RESULTS

Subcellular fractionation of adipocytes
Fractions corresponding to plasma membranes, LDM membranes, high-density microsomes and mitochondria/nuclei were analysed by SDS/PAGE and immunoblotting using antibodies specific to GLUT4 or the TGN marker, TGN38. The results (Figure 1) showed that GLUT4 is predominantly localized to the LDM membrane fraction, and that in response to insulin there is a re-distribution of GLUT4 from this fraction to the plasma membrane; quantification of immunoblots such as that shown in Figure 1 
Immunoadsorption of TGN38Pcontaining vesicles
We next performed a series of immunoadsorption experiments using an antiserum against the C-terminus of TGN38, the results of which are presented in Figure 3 . Immunoblot analysis, using between 5 and 10 % of the total LDM GLUT4 was present in these vesicles, and that this value did not change in response to acute insulin treatment of the cells (i.e. 5-10 % of the GLUT4 present in the LDM at each condition). Analysis of the LDM fractions after adsorption of TGN38-containing vesicles showed no significant decrease in the amount of GLUT4 after this treatment (results not shown).
Immunofluorescence analysis of methanol-fixed 3T3-L1 adipocytes
To assess further the degree of co-localization between TGN38 and GLUT4 in basal cells, we have also performed immuno- Vesicles were isolated by using either anti-GLUT4 or random IgG and run on SDS/PAGE (7% gel). After transfer to nitrocellulose, the blot was probed with antibodies against the M6PR. Lanes: 1, vesicles isolated from resting (basal) cells by using anti-GLUT4; 2, the corresponding sample obtained with random IgG. fluorescence analysis of 3T3-LI adipocytes. Cells were grown on cover-slips and processed for immunofluorescence analysis using either a rabbit polyclonal anti-GLUT4 antiserum or a rabbit polyclonal anti-TGN38 antiserum. Binding of the primary antibodies was detected with a Rhodamine-labelled second antibody. The patterns of staining obtained with either anti-GLUT4 antibodies (Figure 4a ) or anti-TGN38 antibodies (Figure 4b ) are both juxtanuclear, but are clearly different; the anti-GLUT4 antibody gives a distinct focus of staining, whereas that produced by the anti-TGN38 antibody is more reticular. This suggests that the two proteins largely reside in different intracellular compartments.
The bifunctional M6PR/IGFIIR (Morgan et al., 1987) has previously been shown to migrate from an intracellular membrane pool to the plasma membrane in response to insulin treatment in both rat adipocytes and H-35 hepatoma cells (Oppenheimer et al., 1983; Wardzala et al., 1984; Oka et al., 1984; Appell et al., 1988) . It therefore seemed appropriate to compare the pattern of immunofluorescence staining in 3T3-L1 adipocytes observed with a rabbit polyclonal antiserum against GLUT4 with that obtained with a rabbit polyclonal antiserum against M6PR/IGFIIR. As shown in Figure 4 (c), there is some apparent overlap between the two in the juxtanuclear region; however, the anti-M6PR/IGFIIR antiserum (Figure 4c ) additionally recognizes a plethora of dispersed small vesicular structures not detected by the anti-GLUT4 antiserum ( Figure  4a ). Further evidence for an at least partial overlap of GLUT4 and M6PR/IGFIIR is provided by the demonstration of M6PR immunoreactivity in GLUT4-containing vesicles isolated by immunoadsorption ( Figure 5 ). GLUT4 content of TGN38 vesicles after Insulin reversal Cells were stimulated with 100 nM insulin for 30 min at 37°C, and then washed three times in KRM buffer, pH 6.0, conditions which have previously been shown effectively to reverse insulinstimulated glucose transport and result in the re-sequestration of GLUT4 to its intracellular pool (Gibbs et al., 1986) . Analysis of the uptake of deoxyglucose under reversal conditions revealed that insulin-stimulated glucose transport was reversed with a tL of about 7-8 min (Table 1) . A similar ti has been reported by others (Yang and Holman, 1993) . TGN38-containing vesicles were isolated from the LDM fractions of basal cells, cells exposed to insulin for 30 min, and cells exposed to insulin and then 'reversed' by washing in KRM for 5 or 30 min. These vesicles were then analysed for the presence of GLUT4 by immunoblotting, the result of which is shown in Figure 6 . Quantification of the amount of GLUT4 in the TGN38 vesicles indicated that the levels did not significantly change during insulin reversal.
DISCUSSION
It has previously been shown that, after insulin exposure, the levels of GLUT4 at the surface of 3T3-L1 adipocytes increase -20-fold (Calderhead et al., 1990; Holman et al., 1990) . This increase correlates with a loss of GLUT4 from an as yet unidentified intracellular pool. Given the recent observations that GLUT4 undergoes continuous recycling from this pool to the plasma membrane and back (Jhun et al., 1992; Yang and Holman, 1993) , it is clearly relevant to define biochemically and morphologically the intracellular compartment it represents. The TGN would appear to be a prime candidate. In addition to playing a pivotal role in the secretory pathway, sorting newly synthesized proteins to their correct final location (Griffiths and Simons, 1986 ), this organelle is also known to be involved in the recycling of certain proteins from the plasma membrane (Breitfeld et al., 1985; Duncan and Kornfeld, 1986; Stoorvogel et al., 1989; Ladinsky and Howell, 1992; Reaves et al., 1993; Meresse and Hoflack, 1993) . TGN38 is an example of an integral membrane protein which recycles between the TGN and the plasma membrane; however, at steady state, the vast majority of TGN38 is in the TGN (Ladinsky and Howell, 1992; Reaves et al., 1993) . The availability of epitope-mapped polyclonal and monoclonal antibodies to TGN38, as well as antibodies to GLUT4, enabled us to address whether the intracellular pool of GLUT4 is in the TGN.
Analysis of highly purified plasma membrane and LDM membranes isolated from basal or insulin-treated cells demonstrated that GLUT4 is translocated to the plasma membrane in response to insulin, with a concomitant loss of GLUT4 from the LDM fraction (Figure 1 ). However, TGN38 distribution was unaffected by insulin treatment (Figure 1) (Jhun et al., 1992; Yang and Holman, 1993) does not involve significant accumulation of GLUT4 in the TGN. The cells used in Figure 3 were exposed to insulin for 30 min, thus allowing ample time for several rounds of GLUT4 re-cycling, on the basis of the half-times reported by Jhun et al. (1992) and Yang and Holman (1993) . The inability to detect TGN38 in the GLUT4-containing vesicles may be a reflection of the relatively weak immunoblot signal obtained with this antibody (compare the blots in Figure 1 ).
Immunofluorescence analysis ofmethanol-fixed 3T3-L I adipocytes provides further evidence that TGN38 and GLUT4 do not co-localize in these cells. The patterns of staining observed with antibodies to the different proteins are clearly dissimilar ( Figures  4a and 4b ). This set of experiments also confirmed that the intracellular pool of GLUT4 fails to co-localize with either lysosomes or the Golgi stack, but does show some co-localization with the M6PR/IGFIIR (Figures 4c and 5 ). This latter observation is of interest, since others have shown that incubation of rat adipocytes and H-35 hepatoma cells in the presence of insulin leads to an increase in cell-surface IGFII receptors (Oppenheimer et al., 1983; Wardzala et al., 1984; Oka et al., 1984; Appell et al., 1988) . One might therefore expect at least a portion of the intracellular GLUT4 and M6PR/IGFIIR to reside in the same intracellular compartment.
Washing insulin-treated adipocytes with low-pH buffer has been shown to reverse efficiently the stimulation of transport (Gibbs et al., 1986) , and moreover to result in the re-sequestration of GLUT4 to its intracellular compartment (Yang et al., 1992; Yang and Holman, 1993) . We have evaluated the role of the TGN as a sorting point for the re-sequestration of GLUT4 molecules after insulin reversal. We have performed immunoadsorption experiments with anti-TGN38 antibodies from cells which have been maximally stimulated with insulin, then reversed for 5 or 30 min. Table 1 shows that deoxyglucose transport was effectively reversed by this treatment. Analysis of the TGN38-containing vesicles further shows that, even under conditions of re-accumulation of GLUT4 into the intracellular compartment, the extent of the co-localization of GLUT4 and TGN38 does not increase ( Figure 6 ). Thus we suggest that significant accumulation of GLUT4 in the TGN does not occur.
In summary, the data presented herein demonstrate that the insulin-responsive glucose transporter GLUT4 and the TGN marker protein TGN38 do not co-localize within the intracellular vesicles of 3T3-L1 adipocytes. Therefore, we suggest that the intracellular pool to which GLUT4 is localized in resting 3T3-L1 adipocytes is not the TGN. Upon reversal of insulinstimulated glucose transporter translocation, we seen no evidence of GLUT4 re-sequestration involving the TGN.
